Correlation Between Vivos Therapeutics and NeueHealth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and NeueHealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and NeueHealth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and NeueHealth, you can compare the effects of market volatilities on Vivos Therapeutics and NeueHealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of NeueHealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and NeueHealth.

Diversification Opportunities for Vivos Therapeutics and NeueHealth

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vivos and NeueHealth is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and NeueHealth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeueHealth and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with NeueHealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeueHealth has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and NeueHealth go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and NeueHealth

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 5.15 times more return on investment than NeueHealth. However, Vivos Therapeutics is 5.15 times more volatile than NeueHealth. It trades about 0.04 of its potential returns per unit of risk. NeueHealth is currently generating about -0.03 per unit of risk. If you would invest  1,013  in Vivos Therapeutics on August 27, 2024 and sell it today you would lose (693.00) from holding Vivos Therapeutics or give up 68.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vivos Therapeutics  vs.  NeueHealth

 Performance 
       Timeline  
Vivos Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
NeueHealth 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NeueHealth are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, NeueHealth is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Vivos Therapeutics and NeueHealth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivos Therapeutics and NeueHealth

The main advantage of trading using opposite Vivos Therapeutics and NeueHealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, NeueHealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeueHealth will offset losses from the drop in NeueHealth's long position.
The idea behind Vivos Therapeutics and NeueHealth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance